Opinions+
Perspectives on issues affecting biopharma and health care.
Most Read
Improving health care means improving data diversity. Federated learning can help
Why medtech is a different beast than biotech in the life sciences pack
Unprecedented development of Covid-19 vaccines, treatments points to biopharma’s future
The pharma industry needs to measure patient experience from the patients’ perspectives
Developers of microbiome-based drugs face challenges. There are ways to overcome them
Investment in antimicrobials was up in 2020, but much work remains
Making pharma’s post-Covid-19 future faster and smarter
All Coverage
advertisement
